Stomach Neoplasms
📧 Sign up to get email alerts when something new happens for Stomach Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-11-14Clinical Trial Update: Comparisons Between Isoperistaltic and Antiperistaltic Gastrojejunostomy in Laparoscopic Distal Gastrectomy [NA]
Clinical trial update comparing isoperistaltic and antiperistaltic gastrojejunostomy approaches in laparoscopic distal gastrectomy for stoma…
-
CLINICAL_TRIALS trial_result · 2017-09-20Clinical Trial Update: Study of Adjuvant Radiochemotherapy for Gastric Cancer [Phase 1, Phase 2]
Clinical trial update for an adjuvant radiochemotherapy approach in gastric cancer (stomach neoplasms) spanning Phase 1 and Phase 2, status …
-
CLINICAL_TRIALS trial_result · 2017-09-15Clinical Trial Update: Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC [Phase 3]
Phase 3 trial comparing individualized intraperitoneal and systemic chemotherapy to systemic chemotherapy as first-line treatment for advanc…
-
CLINICAL_TRIALS trial_result · 2017-07-21Clinical Trial Update: The Efficacy of Esomeprazole Premedication on Intraoperative Bleeding During Gastric ESD [NA]
This clinical trial update reports on the completed study evaluating whether premedication with esomeprazole reduces intraoperative bleeding…
-
CLINICAL_TRIALS research · 2017-06-14Clinical Trial Update: Pulsed Low Dose Rate Radiation Therapy for Gastric Cancer Patients With Peritoneal Metastasis [NA]
This clinical trial update concerns pulsed low-dose-rate radiation therapy for gastric cancer patients with peritoneal metastasis; status is…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-03-23Clinical Trial Update: Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer [NA]
A clinical trial update describing evaluation of the efficacy and safety of CAR-T therapy for stomach neoplasms.
-
EMA withdrawal · 2016-12-22EMA Withdrawn: Capecitabine SUN (capecitabine) — Sun Pharmaceutical Industries Europe B.V.
Capecitabine SUN (capecitabine) has been withdrawn from the European market by Sun Pharmaceutical Industries Europe B.V.
-
CLINICAL_TRIALS trial_result · 2014-05-13Clinical Trial Update: Surgicel® Fibrillar for Delayed Bleeding After ESD [NA]
A completed clinical trial evaluating Surgicel Fibrillar to prevent delayed bleeding after endoscopic submucosal dissection in patients with…
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: Study of Ixabepilone in Asian Subjects With Unresectable or Metastatic Gastric Cancer [Phase 2]
Phase 2 trial evaluating ixabepilone in Asian patients with unresectable or metastatic gastric cancer has been completed with results posted…
-
EMA withdrawal · 2012-06-14EMA Withdrawn: Docefrez (docetaxel) — Sun Pharmaceutical Industries Europe B.V.
Withdrawn EMA entry for Docefrez (docetaxel) by Sun Pharmaceutical Industries Europe B.V.; listed indications include stomach neoplasms, ade…
-
EMA withdrawal · 2010-03-26EMA Application withdrawn: Docetaxel Mylan (docetaxel) — Mylan S.A.S.
Withdrawal of the EMA application for Docetaxel Mylan (docetaxel) by Mylan S.A.S., affecting multiple solid tumor indications including non-…